11月7日 - FDA批准ProQuad的补充生物制剂申请(SBLA),更新产品说明书以纳入“通过活检检测到的风疹疫苗病毒引起的慢性皮肤肉芽肿”。
11月7日 - FDA批准ProQuad的补充生物制剂申请(SBLA),更新产品说明书以纳入“通过活检检测到的风疹疫苗病毒引起的慢性皮肤肉芽肿”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.